| Financial Year |
March 31 2023 |
| Monetary Funds |
378,031,020.37 |
| Held-for-trading Financial Assets |
470,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
236,467,543.17 |
| Advances to Suppliers |
71,812,505.13 |
| Other Receivables |
2,435,254.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
36,469,815.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,486,894.08 |
| Total Current Assets |
1,200,102,144.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
306,361,100.26 |
| Under-construction Projects |
20,184,689.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,839,253.89 |
| R&D expenses |
38,150,830.91 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,395,909.65 |
| Deferred Income Tax Assets |
30,253,205.71 |
| Other Non-Current Assets |
27,972,248.73 |
| Sub-Total of Non-Current Assets |
532,815,281.92 |
| Total Assets |
1,732,917,426.72 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
256,571,601.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,826,587.53 |
| Taxes Payable |
18,024,188.06 |
| Interest Payable |
-- |
| Dividend Payable |
969,520.00 |
| Other payables |
114,249,497.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,684,115.50 |
| Other Current Liabilities |
729,550.44 |
| Sub-Total of Current Liabilities |
410,850,372.49 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,732,915.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,718,613.52 |
| Total Liabilities |
446,568,986.01 |
| Paid-In Capital(Or Share Stock) |
435,161,500.00 |
| Capital Surplus |
344,525,814.74 |
| Surplus Reserve |
60,923,543.06 |
| LESS:Treasury Stock |
23,797,907.50 |
| Undistributed Profits |
454,040,166.78 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,286,348,440.71 |
| Owner's Equity（Stockholder's Equity） |
1,286,348,440.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,732,917,426.72 |
